Contacts, reporting, and the dated recall distinction: Pfizer Canada contacts, Health Canada complaint guidance, and the FDA-posted 2019 Hospira recall
Still, for wellness clinics and functional-medicine providers, custom formulations hint at GLP-1s longer-term potential in longevity and metabolic optimizationan arena branded drugmakers cant legally market toward
There is also an upside to allowing legitimate compounding
Always consult a licensed healthcare provider before starting or adjusting any medication
GIP and GLP-1 may exert long-term effects on -cell survival and proliferation, potentially delaying the development of and even reversing T2DM
Once a product enters the market, it largely disappears from regulatory view